These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37067353)

  • 1. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.
    Beck RW; Kanapka LG; Breton MD; Brown SA; Wadwa RP; Buckingham BA; Kollman C; Kovatchev B
    Diabetes Technol Ther; 2023 May; 25(5):329-342. PubMed ID: 37067353
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 3. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes.
    Kruger D; Kass A; Lonier J; Pettus J; Raskin P; Salam M; Trikudanathan S; Zhou K; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):697-711. PubMed ID: 36173236
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Town M; Raghinaru D; Lum JW; Brown SA; Buckingham BA
    Diabetes Technol Ther; 2022 Aug; 24(8):588-591. PubMed ID: 35020488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.
    Rizzi A; Tartaglione L; Lucaccini Paoli L; Leo ML; Popolla V; Viti L; Barberio A; Di Leo M; Pontecorvi A; Pitocco D
    Diabetes Obes Metab; 2024 Sep; 26(9):4078-4086. PubMed ID: 39010292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics.
    Henry Z; Villar Fimbel S; Bendelac N; Perge K; Thivolet C
    Diabetes Obes Metab; 2024 Feb; 26(2):557-566. PubMed ID: 37905353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.
    Lynch J; Kanapka LG; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):726-736. PubMed ID: 36173238
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.
    Levy CJ; Bailey R; Laffel LM; Forlenza G; DiMeglio LA; Hughes MS; Brown SA; Aleppo G; Bhargava A; Shah VN; Clements MA; Kipnes M; Bruggeman B; Daniels M; Rodriguez H; Calhoun P; Lum JW; Sasson-Katchalski R; Pinsker JE; Pollom R; Beck RW;
    Diabetes Technol Ther; 2024 Sep; 26(9):652-660. PubMed ID: 38696672
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes.
    Messer LH; Berget C; Pyle L; Vigers T; Cobry E; Driscoll KA; Forlenza GP
    Diabetes Technol Ther; 2021 Dec; 23(12):837-843. PubMed ID: 34096789
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical Care.
    Messer LH; Breton MD
    Diabetes Technol Ther; 2023 Dec; 25(12):877-882. PubMed ID: 37751154
    [No Abstract]   [Full Text] [Related]  

  • 11. A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.
    Beck RW; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Calhoun P
    Diabetes Technol Ther; 2022 Oct; 24(10):681-696. PubMed ID: 36173235
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
    Renard E; Joubert M; Villard O; Dreves B; Reznik Y; Farret A; Place J; Breton MD; Kovatchev BP;
    Diabetes Care; 2023 Dec; 46(12):2180-2187. PubMed ID: 37729080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Jalilova A; Pilan BŞ; Demir G; Özbaran B; Balkı HG; Arslan E; Köse SG; Özen S; Darcan Ş; Gökşen D
    Eur J Pediatr; 2024 Jul; 183(7):3095-3103. PubMed ID: 38661816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    Wadwa RP; Reed ZW; Buckingham BA; DeBoer MD; Ekhlaspour L; Forlenza GP; Schoelwer M; Lum J; Kollman C; Beck RW; Breton MD;
    N Engl J Med; 2023 Mar; 388(11):991-1001. PubMed ID: 36920756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Raghinaru D; Forlenza GP; Isganaitis E; Kudva YC; Lam DW; Levister C; O'Malley G; Church MM; Lum JW; Buckingham B; Brown SA
    J Diabetes Sci Technol; 2023 Jul; 17(4):935-942. PubMed ID: 35473359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.
    Reznik Y; Carvalho M; Fendri S; Prevost G; Chaillous L; Riveline JP; Hanaire H; Dubois S; Houéto P; Pasche H; Mianowska B; Renard E
    Diabetes Obes Metab; 2024 Feb; 26(2):622-630. PubMed ID: 37921083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study.
    Graham R; Mueller L; Manning M; Habif S; Messer LH; Pinsker JE; Aronoff-Spencer E
    Diabetes Technol Ther; 2024 Jan; 26(1):24-32. PubMed ID: 37782904
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    BMC Med; 2024 Apr; 22(1):175. PubMed ID: 38659016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.